Bio

Bio


Keith Morse, MD, MBA, is a pediatric hospitalist and Medical Director of Clinical Informatics at Stanford Medicine. His work in operational and research informatics focuses on meaningful deployment of machine learning in clinical settings. He completed a fellowship in Clinical Informatics at Stanford.

Clinical Focus


  • Pediatrics

Academic Appointments


  • Clinical Assistant Professor, Pediatrics

Administrative Appointments


  • Medical Director of Clinical Informatics, Stanford Children's Health (2020 - Present)

Professional Education


  • Board Certification: American Board of Pediatrics, Pediatrics (2018)
  • Residency: Phoenix Children's Hospital Pediatric Residency (2018) AZ
  • Medical Education: Jefferson Medical College (2015) PA
  • Fellowship, Stanford University, Clinical Informatics (2020)
  • Residency, Phoenix Children's Hospital, Pediatrics (2018)
  • MD, Jefferson Medical College (2015)
  • MBA, Washington University in St. Louis (2009)

Teaching

2020-21 Courses


Publications

All Publications


  • Estimate the hidden deployment cost of predictive models to improve patient care. Nature medicine Morse, K. E., Bagely, S. C., Shah, N. H. 2020; 26 (1): 18?19

    View details for DOI 10.1038/s41591-019-0651-8

    View details for PubMedID 31932778

  • Hospital-Level Variation in Practice Patterns and Patient Outcomes for Pediatric Patients Hospitalized With Functional Constipation. Hospital pediatrics Librizzi, J., Flores, S., Morse, K., Kelleher, K., Carter, J., Bode, R. 2017; 7 (6): 320?27

    Abstract

    Constipation is a common pediatric condition with a prevalence of 3% to 5% in children aged 4 to 17 years. Currently, there are no evidence-based guidelines for the management of pediatric patients hospitalized with constipation. The primary objective was to evaluate practice patterns and patient outcomes for the hospital management of functional constipation in US children's hospitals.We conducted a multicenter, retrospective cohort study of children aged 0 to 18 years hospitalized for functional constipation from 2012 to 2014 by using the Pediatric Health Information System. Patients were included by using constipation and other related diagnoses as classified by International Classification of Diseases, Ninth Revision. Patients with complex chronic conditions were excluded. Outcome measures included percentage of hospitalizations due to functional constipation, therapies used, length of stay, and 90-day readmission rates. Statistical analysis included means with 95% confidence intervals for individual hospital outcomes.A total of 14?243 hospitalizations were included, representing 12?804 unique patients. The overall percentage of hospitalizations due to functional constipation was 0.65% (range: 0.19%-1.41%, P < .0001). The percentage of patients receiving the following treatment during their hospitalization included: electrolyte laxatives: 40% to 96%; sodium phosphate enema: 0% to 64%; mineral oil enema: 0% to 61%; glycerin suppository: 0% to 37%; bisacodyl 0% to 47%; senna: 0% to 23%; and docusate 0% to 11%. Mean length of stay was 1.97 days (range: 1.31-2.73 days, P < .0001). Mean 90-day readmission rate was 3.78% (range: 0.95%-7.53%, P < .0001).There is significant variation in practice patterns and clinical outcomes for pediatric patients hospitalized with functional constipation across US children's hospitals. Collaborative initiatives to adopt evidence-based best practices guidelines could help standardize the hospital management of pediatric functional constipation.

    View details for DOI 10.1542/hpeds.2016-0101

    View details for PubMedID 28522604

Footer Links:

Stanford Medicine Resources: